Soft Tissue Allografts Market Trends

  • Report ID: 4344
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Soft Tissue Allografts Market Growth Drivers and Challenges:

Growth Drivers

  • Growing Incidences of Sports Injuries - Sports injuries happen when exercising or playing a sport. These injuries affect the bones, muscles, tendons, ligaments, and other body structures. As per a report, in the United States, every year, approximately 4 million kids aged 14 and under suffer injuries while playing sports or engaging in leisure activities.

  • Rising Prevalence of Osteoarthritis - Older people have a higher risk to develop osteoarthritis. The breakdown of cartilage, a stretchy material that reduces the friction in joints, causes primary osteoarthritis. For instance, around 3 to 6% of people worldwide suffer from osteoarthritis. It is a cause of moderate to severe impairment in nearly 44 million people.

  • Increase in Trauma Cases – As per the World Health Organization, every year, approximately 1.3 million people's lives are ended prematurely as an outcome of a road accident. Non-fatal injuries affect between 20 and 50 million people who have become disabled as a consequence of their injury. These injuries many times cause wear and tear of bones and muscles, breaking the stability of the skeletal system.

  • Upsurge in Musculoskeletal Diseases - The musculoskeletal issues can affect the muscles, bones, and joints. The severity of MSDs can vary. In some cases, they cause pain and discomfort and in severe situations, it can lead to allografting. Musculoskeletal issues entail a variety of problems, including tendinitis, carpel tunnel syndrome, and fibromyalgia. Nearly 1.71 billion people around the world have musculoskeletal diseases

  • Technological Advancement in Allografts - The newest technology from the CYGNUS family of amniotic tissue allografts, CYGNUS Matrix Disks, was just released, by Vivex Biologics, Inc. With enhanced handling and increased workability, CYGNUS® Matrix Disks are a flexible, multi-layer allograft that preserves the amnion layer

Challenges

  • High treatment cost of soft tissues - The average cost of allograft ACL restoration was around USD 5500. ACL reconstruction is a commonly practiced orthopedic operation. Though there have been many technological advancements in allography, the cost price of the operation is also increasing.  Moreover, in comparison to autografts, allografts are more expensive.
  • Shortage of skilled workers
  • Lack of medical reimbursement policies for soft tissue allografts

Base Year

2025

Forecast Period

2026-2035

CAGR

6.2%

Base Year Market Size (2025)

USD 5.04 Billion

Forecast Year Market Size (2035)

USD 9.2 Billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of soft tissue allografts is assessed at USD 5.32 Billion.

The global soft tissue allografts market size was valued at around USD 5.04 Billion in 2025 and is projected to grow at a CAGR of more than 6.2%, reaching USD 9.2 Billion revenue by 2035.

North America’s soft tissue allografts market will hold around 44.2% share by 2035, driven by rising prevalence of arthritis and associated healthcare expenditure.

Key players in the market include Stryker Corporation, ALON SOURCE GROUP, CONMED Corporation, LifeSciences Corporation, Organogenesis Inc., RTI Surgical, Inc., MIMEDX, Inc., Xtant Medical Holdings, Inc., Globus Medical, Inc., Bone Bank Allografts.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos